Who Pays? Coverage Challenges for Cardiovascular Genetic Testing in U.S. Patients
Inherited cardiovascular conditions are common, and comprehensive care of affected families often involves genetic testing. When the clinical presentations of these conditions overlap, genetic testing may clarify diagnoses, etiologies, and treatments in symptomatic individuals and facilitate the ide...
Main Authors: | Katherine Grace Spoonamore, Nicole M Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-05-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fcvm.2016.00014/full |
Similar Items
-
Why Insurers Are Wrong about Adverse Selection
by: R. Guy Thomas
Published: (2018-04-01) -
Genetic Evaluation and Screening in Cardiomyopathies: Opportunities and Challenges for Personalized Medicine
by: Sahana Aiyer, et al.
Published: (2023-05-01) -
The Australian moratorium on genetics and life insurance: evaluating policy compared to Parliamentary recommendations regarding genetic discrimination
by: Jane Tiller |, et al.
Published: (2022-12-01) -
Privacy Implications of Contacting the At-Risk Relatives of Patients with Medically Actionable Genetic Predisposition, with Patient Consent: A Hypothetical Australian Case Study
by: Jane Tiller, et al.
Published: (2023-06-01) -
Still using genetic data? A comparative review of Canadian life insurance application forms before and after the GNDA
by: Amy Fernando, et al.
Published: (2024-01-01)